RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review.

Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review.

Add to Collection
2022 Jun Others Fist_Author_Year_PM

Full Author : ['Mahapatra, Manoj K', 'Karuppasamy, Muthukumar', 'Sahoo, Biswa M']
Journal Title : Pharmaceutical research
Chapter : Section3
Journal Year : 2022
Cited by : Not Available

INTRODUCTION: Semaglutide, a peptidic GLP-1 receptor agonist, has been clinically approved for treatment of type 2 diabetes mellitus and is available in subcutaneous and oral dosage form. Diabetes, insulin resistance, and obesity are responsible for the p.....

Keywords : ["abate obesity nonalcoholic steatohepatitis", "new receptor agonist", "therapeutic potential", "neurodegenerative disease", "narrative review", "semaglutide"]